**Core Concept**
Psoralen-A is a synthetic compound used in the treatment of skin diseases. It belongs to the class of furanocoumarins, which are known to intercalate into DNA and form cross-links upon activation by ultraviolet A (UVA) light, thereby inhibiting DNA synthesis and causing cell death.

**Why the Correct Answer is Right**
Psoralen-A is used in the treatment of psoriasis, a chronic skin disorder characterized by abnormal keratinocyte proliferation and inflammation. The mechanism of action of Psoralen-A involves the formation of cyclobutane pyrimidine dimers (CPDs) and 6,4-photoproducts upon activation by UVA light, leading to DNA damage and apoptosis of affected cells. This process is mediated by the enzyme cyclobutane pyrimidine dimer photolyase, which is activated by UVA light.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Psoralen-A is not used in the treatment of acne vulgaris, which is typically managed with topical retinoids, antibiotics, or benzoyl peroxide.
**Option B:** This option is incorrect because Psoralen-A is not used in the treatment of atopic dermatitis, which is typically managed with topical corticosteroids, emollients, and phototherapy.
**Option C:** This option is incorrect because Psoralen-A is not used in the treatment of vitiligo, which is typically managed with topical corticosteroids, immunomodulators, and phototherapy.

**Clinical Pearl / High-Yield Fact**
Psoralen-A should be used with caution in patients with a history of skin cancer or porphyria, as it can exacerbate these conditions. Additionally, patients taking Psoralen-A should avoid exposure to direct sunlight and wear protective clothing to minimize the risk of skin burns and photoaging.

**Correct Answer: D. Psoriasis.**